1-2 of 2
Dongsheng Wu
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Phase II study of time-limited treatment with orelabrutinib plus bendamustine and obinutuzumab (OBG) in patients with treatment-Naïve CLL/SLL patients

Free
Xutao Guo, Yunxia Zhang, Xiaolei Wei, Haohao Lei, Qi Wei, Yongqiang Wei, Dongsheng Wu, Ning Su, Ru Feng
Journal: Blood
Blood (2025) 146 (Supplement 1): 7417.
https://doi.org/10.1182/blood-2025-7417
Published: 2025
Journal Articles

Prospective evaluation of venetoclax combined with CLAG regimen in relapsed/refractory acute myeloid leukemia: A multicenter, randomized controlled, open-lable, phase II Trial

Free
Guopan Yu, Yu Zhang, Weihua Zhao, Sijian Yu, Guangyang Weng, Dongsheng Wu, Wenjie Xiong, Danian Nie, Caixia Wang, Xiangjun Fu, Xuan Li, Qifa Liu
Journal: Blood
Blood (2025) 146 (Supplement 1): 1000.
https://doi.org/10.1182/blood-2025-1000
Published: 2025